Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...

Compared to other anti-diabetic drugs, semaglutide, also known as Ozempic, may lower the risk of Alzheimer’s disease in ...

Alzheimer's disease (AD) is a progressive brain disorder that gradually destroys memory and cognitive abilities, affecting ...

Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with ...

Share on PinterestMore evidence suggests that semaglutide drugs could help lower the risk of Alzheimer’s disease. Image ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

Compared to other diabetes medications, semaglutide might offer added protection against Alzheimer’s for type 2 diabetes ...

Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia?

In this week’s Bloom Boost – health news you might have missed, Gayle Guyardo , the host of the nationally syndicated health ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

It’s the active ingredient in Novo Nordisk’s Ozempic and Wegovy; Study done in comparison of seven popular diabetes medicines ...